Literature DB >> 26670434

Altered expression profile of micrornas in gastric stromal tumor.

Jun Xiao1, Qi-Xian Wang2, You-Qing Zhu2.   

Abstract

MicroRNAs (miRNAs) play important roles in carcinogenesis, but the global miRNA expression profile in gastric stromal tumor tissues remains unclear. This study was to examine the miRNA expression profile in gastric stromal tumor tissues and explore the function of dysregulated miRNAs by performing gene ontology (GO) and pathway enrichment analysis. Total RNA was extracted and purified from 3 pairs of frozen gastric stromal tumor tissues and the adjacent non-tumor tissues by using mirVana™ miRNA isolation kit. The miRNA expression was analyzed with Affymetrix microarrays (version 4.0) containing 2578 human mature microRNA probes. The dysregulated microRNAs were validated by quantitative RT-PCR in 30 pairs of gastric stromal tumor tissues. The target gene of the dysregulated microRNAs was predicted by miRanda, TargetScan and PicTar. GO and pathway enrichment analysis was conducted to examine the potential function of miR-3178 and miR-193a-5p. The results showed that there were 12 differently expressed microRNAs in gastric stromal tumor tissues, among which 10 miRNAs were down-regulated, and 2 were up-regulated (P<0.05). The validation results by RT-PCR were in accordance with those by microRNA microarry. GO analysis found that the target genes of miR-3178 were involved in 5 GO terms and those of miR-193a-5p in 7 GO terms in level 2. Pathway enrichment analysis suggested that miR-3178 and miR-193a-5p were related to 57 and 122 signaling pathways, respectively. It was concluded that gastric stromal tumor displays a unique miRNA signature. This specific expression may become a new diagnostic and prognostic biomarker for gastric stromal tumor. miR-3178 and miR-193a-5p function as suppressive microRNAs, and they may also become diagnosis and treatment targets for gastric stromal tumor.

Entities:  

Keywords:  gastric stromal tumor; gene; microRNA; signal pathway

Mesh:

Substances:

Year:  2015        PMID: 26670434     DOI: 10.1007/s11596-015-1516-0

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  31 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

3.  Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31.

Authors:  Florian Haller; Anja von Heydebreck; Jitao David Zhang; Bastian Gunawan; Claus Langer; Giuliano Ramadori; Stefan Wiemann; Ozgür Sahin
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

Review 4.  Additional Primary Malignancies in Patients with Gastrointestinal Stromal Tumor (GIST): A Clinicopathologic Study of 260 Patients with Molecular Analysis and Review of the Literature.

Authors:  Jaclyn Frances Hechtman; Ronald DeMatteo; Khedoudja Nafa; Ping Chi; Maria E Arcila; Snjezana Dogan; Alifya Oultache; Wen Chen; Meera Hameed
Journal:  Ann Surg Oncol       Date:  2015-01-07       Impact factor: 5.344

5.  Multiple sporadic gastrointestinal stromal tumors concomitant with ampullary adenocarcinoma: a case report with KIT and PDGFRA mutational analysis and miR-221/222 expression profile.

Authors:  Stella Blandamura; Lara Alessandrini; Roberta Bertorelle; Francesca Simonato; Vincenza Guzzardo; Elisa Valentini; Imerio Angriman; Ambrogio Fassina
Journal:  Pathol Res Pract       Date:  2014-03-05       Impact factor: 3.250

6.  Imatinib mesylate in clinically suspected gastric stromal tumors.

Authors:  Zi-Yu Li; Lei Tang; Shuang-Xi Li; Fei Shan; Zhao-De Bu; Jia-Fu Ji
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

Review 7.  Gastrointestinal stromal tumor: recent advances in pathology and genetics.

Authors:  Hidetaka Yamamoto; Yoshinao Oda
Journal:  Pathol Int       Date:  2014-11-20       Impact factor: 2.534

8.  [Endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA) as primary diagnostic tool for unclear lesions in the upper gastrointestinal tract].

Authors:  M Moehler; J Voigt; M Kastor; M Heil; C Sengespeick; S Biesterfeld; W Dippold; S Kanzler; P R Galle
Journal:  Dtsch Med Wochenschr       Date:  2011-02-07       Impact factor: 0.628

9.  Gastrointestinal stromal tumor.

Authors:  Xiaohui Zhao; Changjun Yue
Journal:  J Gastrointest Oncol       Date:  2012-09

10.  MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.

Authors:  C M M Gits; P F van Kuijk; M B E Jonkers; A W M Boersma; W F van Ijcken; A Wozniak; R Sciot; P Rutkowski; P Schöffski; T Taguchi; R H J Mathijssen; J Verweij; S Sleijfer; M Debiec-Rychter; E A C Wiemer
Journal:  Br J Cancer       Date:  2013-08-22       Impact factor: 7.640

View more
  4 in total

1.  miR-3178 as a prognostic indicator and tumor suppressor of gastric cancer.

Authors:  Jin-Cheng Wu; Zhao-Hui Liu; Xiaomei Ding; Rui-Sheng Ke
Journal:  Ir J Med Sci       Date:  2021-02-05       Impact factor: 1.568

2.  LINC01224 accelerates malignant transformation via MiR-193a-5p/CDK8 axis in gastric cancer.

Authors:  Hui Sun; Jihong Yan; Guangyu Tian; Xiaojun Chen; Wenbo Song
Journal:  Cancer Med       Date:  2021-02       Impact factor: 4.452

3.  Down-regulation of the Sp1 transcription factor by an increase of microRNA-4497 in human placenta is associated with early recurrent miscarriage.

Authors:  Huaiyun Tang; Linqing Pan; Yun Xiong; Leilei Wang; Yugui Cui; Jiayin Liu; Lisha Tang
Journal:  Reprod Biol Endocrinol       Date:  2021-02-12       Impact factor: 5.211

4.  LINC00152 down-regulated miR-193a-3p to enhance MCL1 expression and promote gastric cancer cells proliferation.

Authors:  Yong Huang; Hui Luo; Fang Li; Yun'e Yang; Guangsheng Ou; Xiaolong Ye; Nianchu Li
Journal:  Biosci Rep       Date:  2018-05-08       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.